Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N05AX08	RISPERDAL	B	Risperidone - 1mg/ml	1mg/ml	Solution	1,377,439 L.L
N05AX08	RISPERDAL	B	Risperidone - 1mg/ml	1mg/ml	Solution	1,377,439 L.L
R01AB08	RINOFLUIMUCIL	B	Acetylcysteine - 1%, Tuaminoheptane sulfate - 0.5%, Benzalkonium chloride - 0.0125%		Solution	419,279 L.L
R01AD08	RINISONA	G	Fluticasone propionate - 50mcg/actuation	50mcg/dose	Spray, suspension	556,351 L.L
R01AD11	RINEX	G	Triamcinolone acetonide - 55mcg/actuation	55mcg/actuation	Spray, suspension	470,985 L.L
J07BH01	ROTATEQ ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT	B	Rotavirus G1, live attenuated - ?2.2x106 IU, Rotavirus G2, live attenuated - ?2.8x106 IU, Rotavirus G3, live attenuated - ?2.2x106 IU, Rotavirus G4, live attenuated - ?2.0x106 IU, Rotavirus P1, live attenuated - ?2.3x106 IU		Suspension	4,508,592 L.L
J07BH01	ROTARIX ORAL	B	Rota virus human RIX4414, live attenuated - ?106 CCID50		Suspension	5,167,074 L.L
J07BH01	ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL FREEZE-DRIED)	BioTech	Rotavirus bovine-human , live attenuated -		Suspension	2,822,069 L.L
R05DB13	RAPICOD	G	Butamirate citrate - 0.15%	0.15%	Syrup	296,989 L.L
R06AX27	RINA	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Syrup	159,917 L.L
C09AA05	RAMIPRIL-REMEDICA	G	Ramipril - 10mg	10mg	Tablet	896,343 L.L
N02CC04	RIZATRIPTAN ARROW	G	Rizatriptan - 10mg	10mg	Tablet	1,182,581 L.L
M01AB05	REMETHAN	G	Diclofenac sodium - 50mg	50mg	Tablet	196,201 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 2mg	2mg	Tablet	831,839 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 0.5mg	0.5mg	Tablet	831,839 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 1mg	1mg	Tablet	831,839 L.L
G04BE08	RAVANA	G	Tadalafil - 20mg	20mg	Tablet	500,421 L.L
P01AB01	RAMAZOL	G	Metronidazole - 500mg	500mg	Tablet	216,359 L.L
G04BE08	RAVANA	G	Tadalafil - 5mg	5mg	Tablet	1,501,264 L.L
C10AA07	ROVASTIN	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet	560,574 L.L
C10AA07	ROVASTIN	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet	560,574 L.L
L04AA10	RAPAMUNE	B	Sirolimus - 1mg	1mg	Tablet	12,907,489 L.L
L04AA10	RAPAMUNE	B	Sirolimus - 1mg	1mg	Tablet	L.L
R06AX28	RUPATADINE BIOGARAN	G	Rupatadine - 10mg	10mg	Tablet	341,336 L.L
N04BD02	RASAGILINE BIOGARAN	G	Rasagiline - 1mg	1mg	Tablet	5,214,109 L.L
N04BD02	RAZYLECT 1	G	Rasagiline mesylate - 1mg	1mg	Tablet	3,532,514 L.L
N04BD02	RAZYLECT 0.5	G	Rasagiline mesylate - 0.5mg	0.5mg	Tablet	2,036,369 L.L
N06BA04	RITALIN	B	Methylphenidate HCl - 10mg	10mg	Tablet	376,276 L.L
M02AA31	ROXONIN	B	Loxoprofen (Sodium) - 60mg	60mg	Tablet	788,836 L.L
M02AA31	ROXONIN	B	Loxoprofen (Sodium) - 60mg	60mg	Tablet	1,295,464 L.L